Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Global Future City Holding Inc stock logo
FTCY
Global Future City
$0.00
$0.05
$1.00
$2.04M-0.614,221 shs16 shs
Immune Therapeutics, Inc. stock logo
IMUN
Immune Therapeutics
$0.09
$0.09
$0.07
$1.30
$7.78M0.4615,246 shs12 shs
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
$0.00
$1.50
$19.37
$7.07M2.899,592 shs4,300 shs
ObsEva SA stock logo
OBSV
ObsEva
$0.00
+400.0%
$0.00
$0.08
$2.14
$39K0.688.94 million shs110 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Global Future City Holding Inc stock logo
FTCY
Global Future City
0.00%0.00%0.00%0.00%0.00%
Immune Therapeutics, Inc. stock logo
IMUN
Immune Therapeutics
0.00%0.00%0.00%0.00%0.00%
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
ObsEva SA stock logo
OBSV
ObsEva
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/AN/AN/AN/AN/AN/A
Immune Therapeutics, Inc. stock logo
IMUN
Immune Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
ObsEva SA stock logo
OBSV
ObsEva
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Global Future City Holding Inc stock logo
FTCY
Global Future City
0.00
N/AN/AN/A
Immune Therapeutics, Inc. stock logo
IMUN
Immune Therapeutics
0.00
N/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
0.00
N/AN/AN/A
ObsEva SA stock logo
OBSV
ObsEva
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/AN/AN/AN/A
Immune Therapeutics, Inc. stock logo
IMUN
Immune Therapeutics
N/AN/AN/AN/A($0.03) per shareN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
$23.99M0.00N/AN/A$0.05 per share0.00
ObsEva SA stock logo
OBSV
ObsEva
N/AN/AN/AN/A$0.41 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Immune Therapeutics, Inc. stock logo
IMUN
Immune Therapeutics
-$3.54MN/A0.00N/AN/AN/A-544.75%N/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
-$8.28M-$4.16N/A0.00N/A-34.51%-682.54%-78.57%N/A
ObsEva SA stock logo
OBSV
ObsEva
-$58.38M-$0.92N/AN/AN/A-416.36%-92.01%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/AN/AN/A
Immune Therapeutics, Inc. stock logo
IMUN
Immune Therapeutics
N/AN/AN/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
N/AN/AN/AN/AN/A
ObsEva SA stock logo
OBSV
ObsEva
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/AN/AN/A
Immune Therapeutics, Inc. stock logo
IMUN
Immune Therapeutics
N/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
N/A
0.68
0.36
ObsEva SA stock logo
OBSV
ObsEva
N/A
0.61
0.61

Institutional Ownership

CompanyInstitutional Ownership
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/A
Immune Therapeutics, Inc. stock logo
IMUN
Immune Therapeutics
N/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
10.38%
ObsEva SA stock logo
OBSV
ObsEva
17.52%

Insider Ownership

CompanyInsider Ownership
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/A
Immune Therapeutics, Inc. stock logo
IMUN
Immune Therapeutics
50.59%
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
16.43%
ObsEva SA stock logo
OBSV
ObsEva
14.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Global Future City Holding Inc stock logo
FTCY
Global Future City
N/A40.66 millionN/ANot Optionable
Immune Therapeutics, Inc. stock logo
IMUN
Immune Therapeutics
283.66 million41.34 millionNot Optionable
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
122.36 millionN/ANot Optionable
ObsEva SA stock logo
OBSV
ObsEva
5077.97 million66.74 millionNot Optionable

Recent News About These Companies

ObsEva Announces Update on Board of Directors
ObsEva SA OBSN
ObsEva SA OBSEF
ObsEva (NASDAQ: OBSV)
ObsEva Annual Report 2022 - Marketscreener.com
ObsEva Annual Report 2022 - Yahoo Finance
ObsEva Annual Report 2022 - Benzinga
ObsEva Annual Report 2022 - EIN News

Media Sentiment Over Time

Global Future City stock logo

Global Future City OTCMKTS:FTCY

Global Future City Holding, Inc. is an holding company. It focused in the areas of consumer product sales and EB-5 investments. The company was founded on October 12, 2000 and is headquartered in Irvine, CA.

Immune Therapeutics stock logo

Immune Therapeutics OTCMKTS:IMUN

$0.09 0.00 (0.00%)
As of 10/19/2023

Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. is based in Winter Park, Florida.

Innovus Pharmaceuticals stock logo

Innovus Pharmaceuticals OTCMKTS:INNVD

Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream for penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement for promoting sexual health; and Androferti, a natural supplement to support male reproductive health and sperm quality. The company also offers Beyond Human testosterone booster, ketones, krill oil, omega 3 fish oil, Vision Formula, blood sugar, colon cleanse, green coffee extract, and growth agent; RecalMax for brain health; UriVarx, a supplement for overactive bladder and urinary incontinence; PEVarx, a supplement for peak sexual performance; ProstaGorx, a supplement for prostate support; and FlutiCare, a nasal spray. In addition, its products include Apeaz for pain relief; AllerVarx for allergy relief; ArthriVarx for joint pain; Xyralid, a hemorrhoid cream; Can-C eye drop and eye care capsule; MZS, a melatonin formula to enhance sleep patterns; and Diabasens, a diabetic foot cream. The company's pipeline products comprise UriVarx for urinary tract infection; Xyralid suppositories for hemorrhoidal symptoms; GlucoGorx supplement, glucometer, lancing device, and GlucoGorx strip for blood sugar levels; Vesele and RecalMax nitric oxide strips. It markets and sells its products through commercial partners to primary care physicians, urologists, gynecologists, and therapists, as well as to other healthcare providers; and directly to consumers through online channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.

ObsEva stock logo

ObsEva NASDAQ:OBSV

$0.0005 +0.00 (+400.00%)
As of 07/15/2025

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.